Volver

IQVIA Holdings Inc

Ticker: IQV ISIN: US46266C1053
Añadir al portafolio Análisis de cartera en 2min
Stock Large-cap High beta Trading above 200-day average Near 52-week high
Capitalización
37,85 MM $
P/E
30,57
Forward P/E
16,98
Profit margin
8,07%
Revenue growth QoQ
5,20%
Beta
1,37
260,24 $ 0,16%
Precio a fecha de 2026-08-24 · NYSE

Rendimiento por período

Rendimientos acumulados
1 Month +22,05%
6 Months +57,84%
1 Year +38,41%
5 Years +0,14% p.a.+0,68%
10 Years +12,90% p.a.+236,14%
Since inception +14,69% p.a.+518,00%
Rendimientos por año
YTD +15,45%
2025 +14,71%
2024 -15,07%
2023 +12,93%
2022 -27,38%
2021 +57,47%

Key stats

Market cap
37,85 MM
P/E
30,57
Beta
1,37
52-week range
134.65 - 234.30
50-day MA
216,12
200-day MA
181,12
Section 1

Business overview

Company profile data from fundamentals.

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. It has a strategic collaboration with Sarah Cannon Research Institute to enhance clinical trial processes. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is based in Durham, North Carolina.

Sector Healthcare
Industry Diagnostics & Research
Country United States
Exchange NYSE
Section 2

Financial quality

Above-average volatility

Profitability and balance-sheet quality indicators from reported fundamentals.

Profitability

ROE 19,37%
ROA 5,07%
Profit margin 8,07%
Operating margin 13,98%
PEG ratio 0,94
Revenue/share TTM 91,31
Revenue TTM 15,90 MM
EBITDA 2,93 MM
Gross profit TTM 5,37 MM
Beta 1,37

Valuation

Trailing P/E 30,57
Forward P/E 16,98
P/B 6,14
P/S 2,38
EV/EBITDA 14,87
EV/Revenue 3,21

ESG Scores

Total ESG 26,8
Environment 1,2
Social 14,8
Governance 6,9
Section 3

Earnings

Earnings metrics from company highlights and earnings datasets.

EPS estimate (current year) 11,89
Quarterly earnings growth 24,50%
Revenue TTM 15,90 MM
Reported quarters 52
Section 4

Dividends & corporate actions

Dividend and split fields from fundamentals.

Forward annual div. yield 0,00%
Last split date 0000-00-00
Section 5

Ownership / analyst view

Institutional ownership and analyst estimate fields when available.

Analyst

Analyst target price 250,00 $
Analyst rating 4.3044

Ownership & short interest

Shares outstanding 170,30 M
Shares float 161,74 M
Institutional ownership 100,61%
Insider ownership 1,05%
Short ratio 3,65
Short % of float 3,78%

Details

Instrument metadata and source update timestamps.

Symbol IQV
Name IQVIA Holdings Inc
Asset type STOCK
Exchange NYSE
Currency USD
ISIN US46266C1053
Country USA
Code + exchange IQV.NYSE
Fundamentals updated 2025-12-15

La información proporcionada en esta plataforma es solo para fines informativos y no debe considerarse como asesoramiento financiero o de inversión. Insightfolio no ofrece asesoramiento financiero, recomendaciones personalizadas ni orientación sobre la compra, tenencia o venta de activos financieros. Las herramientas y contenidos son únicamente educativos y no están adaptados a las circunstancias, necesidades financieras u objetivos personales.

Insightfolio no asume ninguna responsabilidad por la precisión, integridad o fiabilidad de la información presentada. Es responsabilidad exclusiva de los usuarios verificar la información y tomar decisiones independientes basándose en su propia investigación y consideración. El uso de esta plataforma no reemplaza la consulta con profesionales financieros cualificados.

Invertir implica riesgos. Los usuarios deben ser conscientes de que el valor de las inversiones puede fluctuar y que los rendimientos pasados no son garantía de resultados futuros. Las decisiones de inversión deben basarse en objetivos financieros personales, tolerancia al riesgo y una evaluación independiente de la información relevante.

Insightfolio no respalda ni garantiza la idoneidad de ningún producto financiero, valor o estrategia en particular. Cualquier proyección, pronóstico o escenario hipotético presentado en la plataforma es solo ilustrativo y no constituye una garantía.

Al acceder a los servicios, información o contenido ofrecido por Insightfolio, los usuarios reconocen y aceptan los términos de este aviso legal. Si no estás de acuerdo con estos términos, por favor no uses nuestra plataforma.

Logotipos de instrumentos proporcionados por Elbstream.